1. "Breast Medicine Service"
  2. "Surgery"
  3. "David Jones"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (10)
Groups
  1. Breast Medicine Service (23)
  2. Department of Medicine (23)
  3. GSK Faculty (23)
  4. Solid Tumor Oncology Division (23)
  5. Surgery (23)
  6. Thoracic Oncology (20)

More Groups

People
  1. David Jones (23)
  2. Charles Rudin (17)
  3. Bob Li (12)
  4. James Isbell (12)
  5. Pedram Razavi (12)
  6. David Solit (10)

More People

Years
  1. 2023 (1)
  2. 2022 (6)
  3. 2021 (3)
  4. 2020 (6)
  5. 2019 (5)
  6. 2018 (2)
Publications
  1. Journal of Clinical Oncology (6)
  2. Cancer Research (4)
  3. Cancer Discovery (3)
  4. Cell (2)
  5. Clinical Cancer Research (2)
  6. Nature Medicine (2)

More Publications

Publishers
  1. American Association for Cancer Research (10)
  2. American Society of Clinical Oncology (6)
  3. Cell Press (2)
  4. Elsevier Inc. (2)
  5. Nature Publishing Group (2)
  6. Elsevier Ireland Ltd. (1)

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic and predictive implications of plasma ctDNA in guiding first-line targeted therapy for metastatic HER2 -mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Liu, S. Y.; Jee, J.; Santini, F. C.; Schoenfeld, A. J.; Eichholz, J.; Johnson, K.; Martinez, A.; Guo, J.; Riaz, N.; Lee, N. Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The lung pro-thrombotic niche drives cancer-associated thromboembolism via exosomal ITGB2
    Meeting Abstract

    Lucotti, S.; Ogitani, Y.; Kenific, C. M.; Bojmar, L.; Cioffi, M.; Lauritzen, P.; Molina, H.; Heissel, S.; Lengel, H. B.; Jing, X.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The lung pro-thrombotic niche drives cancer-associated thromboembolism and metastasis via extracellular vesicle ITGB2
    Meeting Abstract

    Lucotti, S.; Ogitani, Y.; Kenific, C. M.; Bojmar, L.; Cioffi, M.; Lauritzen, P.; Molina, H.; Heissel, S.; Lengel, H. B.; Jing, X.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non-small cell lung cancer (NSCLC) treated with definitive radiation therapy
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y. R.; Jee, J.; Kalashnikova, E.; Feeney, J.; Sethi, H.; Aleshin, A.; Kris, M. G.; Chaft, J. E.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants impact clinicopathology of advanced lung cancer
    Journal Article

    Mukherjee, S.; Bandlamudi, C.; Hellmann, M. D.; Kemel, Y.; Drill, E.; Rizvi, H.; Tkachuk, K.; Khurram, A.; Walsh, M. F.; Zauderer, M. G.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; RivieĢ€re, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
    Journal Article

    Mondaca, S.; Lebow, E. S.; Namakydoust, A.; Razavi, P.; Reis-Filho, J. S.; Shen, R.; Offin, M.; Tu, H. Y.; Murciano-Goroff, Y.; Xu, C.; more...
    Lung Cancer (2021)

    Fulltext@MSK | Save
  • KRAS(G12C) mutation is associated with increased risk of recurrence in surgically resected lung adenocarcinoma
    Journal Article

    Jones, G. D.; Caso, R.; Tan, K. S.; Mastrogiacomo, B.; Sanchez-Vega, F.; Liu, Y.; Connolly, J. G.; Murciano-Goroff, Y. R.; Bott, M. J.; Adusumilli, P. S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save